Curb your marketing
This article was originally published in The Tan Sheet
Weight-loss patch manufacturer Curb Your Cravings should discontinue its marketing claims until "reliable and competent" testing is conducted on the product, the Electronic Retailing Self-Regulation Program recommends. The Council of Better Business Bureaus subsidiary took issue with the company's emails and online ads that included claims such as "lose up to 30 pounds in 30 days" and "put on the Patch, take off the pounds." Curb Your Cravings' claims were brought to ERSP's attention by a consumer complaint. The company disagrees with ERSP's decision, but "will modify its advertising and discontinue the use of the general performance claims," the firm states...
You may also be interested in...
Public Company Edition: Mergers with special purpose acquisition corporations may be heating up, but in addition to the Surrozen and Tango SPAC deals Recursion and Biomea launched initial public offerings. Also, Organon sells $5.6bn worth of notes to fund spinout from Merck & Co.
Efforts to improve trial diversity predate COVID-19, but the pandemic’s disproportionate effects on minority communities have brought the issue to the forefront.
Legend/J&J’s CAR-T cilta-cel and Chi-Med’s surufatinib would follow BeiGene’s Brukinsa, which won FDA approval in November 2019.